Compare Cipta Sarana Medika Tbk. (DKHH) vs Sinergi Inti Plastindo Tbk. (ESIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Sarana Medika Tbk. vs Sinergi Inti Plastindo Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Sinergi Inti Plastindo Tbk. trades at Rp128 (market cap 139.85B, 66.98M 24h volume). The key difference: Cipta Sarana Medika Tbk. and Sinergi Inti Plastindo Tbk. are close in size by market cap, and Sinergi Inti Plastindo Tbk. is more actively traded (66.98M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | ESIP | |
|---|---|---|
Market Cap | 158.12B | 139.85B |
Volume | 8.21M | 66.98M |
Lot | 82.15K | 669.81K |
Turnover | 515.2M | 8.73B |
Average Price | 62.72 | 130.29 |
Value | 515.2M | 8.73B |
Indicative Equilibrium Price | 63 | 128 |
Indicative Equilibrium Volume | 1.33K | 7.61K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →About Sinergi Inti Plastindo Tbk.
PT Sinergi Inti Plastindo Tbk (the”Company”) was established based on the notarial deed No.123 dated October 12, 2001 from Dr. Irawan Soerodjo, S.H., M.Si., Notary in Jakarta. PT Tanindo Omega Pasifik is a ultimate parent entity.
Read more on ESIP →
